Compare Align Technology, Inc. (ALGN) vs Vanguard Total International Stock Index Fund ETF (VXUS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Vanguard Total International Stock Index Fund ETF — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Vanguard Total International Stock Index Fund ETF trades at $84.65. The key difference: Vanguard Total International Stock Index Fund ETF is trading nearer its 52-week high, Align Technology, Inc. nearer its low. Which is the better fit depends on your goals.
| ALGN | VXUS | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Sector/Thematic |
52-Week High | $207.19 | $87.06 |
52-Week Low | $124.88 | $68.24 |
Enterprise Value | $11.92B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
VXUS trades at $85.34, up 0.52% on the day, with a neutral technical signal and bullish moving averages. The ETF offers broad international equity exposure across 8,738 stocks, providing diversification benefits. Recent news highlights its role in portfolio construction amid high U.S. valuations, with Vanguard surpassing iShares as the largest ETF provider in June 2026.
The outlook for VXUS is supported by its low-cost structure and global diversification, appealing for long-term investors seeking non-U.S. exposure. Risks include currency fluctuations and emerging market volatility. Analyst sentiment is neutral, with the ETF positioned as a core holding for balanced portfolios.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Vanguard Total International Stock Index Fund ETF
VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →
